UTICA, N.Y., Jan. 29 /PRNewswire-FirstCall/ -- CONMED Corporation (Nasdaq:
CNMD) and Dolphin Medical, Inc., a majority-owned subsidiary of OSI Systems,
Inc. (Nasdaq: OSIS), today announced an agreement under which CONMED will
become the exclusive North American distributor for a full line of pulse
oximetry products manufactured by Dolphin. Pulse oximeters are used in
critical care to continuously monitor a patient's arterial blood oxygen
saturation (SpO2) and pulse rate.
The oximetry products include a full line of sensors compatible with the
installed base of market leader Nellcor Puritan Bennett, Inc. Dolphin's line
has become available in the United States as a result of the expiration of key
Nellcor U.S. patents in November 2003. The distribution agreement also
includes the Dolphin ONE (Oximetry Noise Elimination) products, which are
Dolphin's proprietary all-digital oximeters. CONMED will begin selling
Dolphin's pulse oximetry line in the first calendar quarter of 2004 and
expects first-year revenues in the range of $2 million to $3 million.
Mr. Joseph J. Corasanti, President and Chief Operating Officer of CONMED,
said, "The Dolphin pulse oximetry line will be sold by our Patient Care sales
group, in line with our strategy of adding products to leverage our
distribution strengths. We look forward to introducing these oximetry
products to our customers because of the clinical and economic value they will
provide."
Mr. Dan Goldberger, President of Dolphin Medical, Inc. said, "We are very
pleased that Conmed's Patient Care sales group will be distributing our
products to clinicians who finally have an alternative to Nellcor's oximetry
products. Dolphin's compatible sensor line offers incomparable quality and
value. Dolphin ONE (Oximetry Noise Elimination) is the solution for
challenging situations of low perfusion or motion artifact."
CONMED Profile
CONMED is a medical technology company specializing in instruments,
implants, and video equipment for arthroscopic sports medicine, and powered
surgical instruments, such as drills and saws, for orthopedic, ENT, neuro-
surgery, and other surgical specialties. The Company is also a leading
developer, manufacturer and supplier of RF electrosurgery systems used
routinely to cut and cauterize tissue in nearly all types of surgical
procedures worldwide, endoscopy products such as trocars, clip appliers,
scissors, and surgical staplers. The Company offers integrated operating room
design and intensive care unit service managers. The Company also
manufactures and sells a full line of ECG electrodes for heart monitoring and
other patient care products. Headquartered in Utica, New York, the Company's
2,600 employees distribute its products worldwide from eleven manufacturing
locations.
OSI Systems Profile
OSI Systems Inc. is a diversified global developer, manufacturer and
seller of security and inspection systems, medical monitoring products, and
optoelectronic-based components and systems. The company has more than 30
years of optoelectronics experience, and through its family of subsidiaries,
competes in three specific growth areas: OEM Manufacturing, Security and
Inspection Systems, and Medical Devices. For more information on OSI Systems
Inc. or any of its subsidiary companies, visit http://www.osi-systems.com.
Forward Looking Information
This press release contains forward-looking statements based on certain
assumptions and contingencies that involve risks and uncertainties. The
forward-looking statements are made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995 and relate to the
Company's performance on a going-forward basis. The forward-looking
statements in this press release involve risks and uncertainties which could
cause actual results, performance or trends, including the above mentioned
anticipated revenues and earnings, to differ materially from those expressed
in the forward-looking statements herein or in previous disclosures. The
Company believes that all forward-looking statements made by it have a
reasonable basis, but there can be no assurance that management's
expectations, beliefs or projections as expressed in the forward-looking
statements will actually occur or prove to be correct. In addition to general
industry and economic conditions, factors that could cause actual results to
differ materially from those discussed in the forward-looking statements in
this press release include, but are not limited to: (i) the failure of any one
or more of the assumptions stated above, to prove to be correct; (ii) the
risks relating to forward-looking statements discussed in the Company's Annual
Report on Form 10-K for the fiscal year ended December 31, 2002; (iii)
cyclical purchasing patterns from customers, end-users and dealers; (iv)
timely release of new products, and acceptance of such new products by the
market; (v) the introduction of new products by competitors and other
competitive responses; (vi) the possibility that any new acquisition or other
transaction may require the Company to reconsider its financial assumptions
and goals/targets; and/or (vii) the Company's ability to devise and execute
strategies to respond to market conditions.
SOURCE CONMED Corporation
 back to top
Related links:
http://www.conmed.com
http://www.osi-systems.com
Company News On-Call:
http://www.prnewswire.com/comp/201850.html
CONTACT:
Robert Shallish, +1-315-624-3206, CFO of
CONMED Corporation; or Sanjay Sabnani, +1-310-349-2245, or
sanjay@typcap.com, for OSI Systems, Inc.
|
